These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 1734738)

  • 1. An empirical evaluation of the Global Deterioration Scale for staging Alzheimer's disease.
    Eisdorfer C; Cohen D; Paveza GJ; Ashford JW; Luchins DJ; Gorelick PB; Hirschman RS; Freels SA; Levy PS; Semla TP
    Am J Psychiatry; 1992 Feb; 149(2):190-4. PubMed ID: 1734738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empirical evaluation of the global deterioration scale for staging Alzheimer's disease.
    Reisberg H; Ferris SH; Sclan SG
    Am J Psychiatry; 1993 Apr; 150(4):680-2. PubMed ID: 8465902
    [No Abstract]   [Full Text] [Related]  

  • 3. The Global Deterioration Scale for assessment of primary degenerative dementia.
    Reisberg B; Ferris SH; de Leon MJ; Crook T
    Am J Psychiatry; 1982 Sep; 139(9):1136-9. PubMed ID: 7114305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The construct of minor and major depression in Alzheimer's disease.
    Starkstein SE; Jorge R; Mizrahi R; Robinson RG
    Am J Psychiatry; 2005 Nov; 162(11):2086-93. PubMed ID: 16263848
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Memantine effects measured with the Relevant Outcome Scale for Alzheimer's disease in an open-label, single-arm, multicenter clinical study.
    Holthoff V; Ferris S; Gauthier S; Ihl R; Robert P; Winblad B; Sternberg K; Tennigkeit F;
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):164-72. PubMed ID: 22492589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Validation of the Hungarian version of Alzheimer's Disease Assessment Scale--cognitive subscale].
    Pákáski M; Drótos G; Janka Z; Kálmán J
    Orv Hetil; 2012 Mar; 153(12):461-6. PubMed ID: 22411219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer's disease.
    Zubenko GS; Zubenko WN; McPherson S; Spoor E; Marin DB; Farlow MR; Smith GE; Geda YE; Cummings JL; Petersen RC; Sunderland T
    Am J Psychiatry; 2003 May; 160(5):857-66. PubMed ID: 12727688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Correlations between cognition and function in Alzheimer's disease: based on the abbreviated Barcelona Test (a-BT)].
    Peña-Casanova J; Monllau A; Böhm P; Blesa González R; Aguilar Barberà M; Sol JM; Hernández G;
    Neurologia; 2005; 20(1):4-8. PubMed ID: 15704015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The severe impairment battery: concurrent validity and the assessment of longitudinal change in Alzheimer's disease. The Alzheimer's Disease Cooperative Study.
    Schmitt FA; Ashford W; Ernesto C; Saxton J; Schneider LS; Clark CM; Ferris SH; Mackell JA; Schafer K; Thal LJ
    Alzheimer Dis Assoc Disord; 1997; 11 Suppl 2():S51-6. PubMed ID: 9236953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The Global Deterioration Scale (GDS) and Functional Assessment Staging (FAST) in the diagnosis of Alzheimer type dementia].
    Krzymińska E; Rossa G; Krzymiński S
    Psychiatr Pol; 1993; 27(2):129-38. PubMed ID: 8378466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.
    Dukoff R; Sunderland T
    Am J Psychiatry; 1997 Aug; 154(8):1070-5. PubMed ID: 9247391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Performance-Based instrument to assess functional capacity in dementia: The Texas Functional Living Scale.
    Cullum CM; Saine K; Chan LD; Martin-Cook K; Gray KF; Weiner MF
    Neuropsychiatry Neuropsychol Behav Neurol; 2001; 14(2):103-8. PubMed ID: 11417663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does cognitive impairment influence burden in caregivers of patients with Alzheimer's disease?
    Germain S; Adam S; Olivier C; Cash H; Ousset PJ; Andrieu S; Vellas B; Meulemans T; Reynish E; Salmon E;
    J Alzheimers Dis; 2009; 17(1):105-14. PubMed ID: 19494435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Awareness of disease is different for cognitive and functional aspects in mild Alzheimer's disease: a one-year observation study.
    Sousa MF; Santos RL; Nogueira ML; Belfort T; Rosa RD; Torres B; Simões P; Mograbi DC; Laks J; Dourado MC
    J Alzheimers Dis; 2015; 43(3):905-13. PubMed ID: 25125460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Quality of life in Alzheimer's disease].
    Baquero M; Peset V; Burguera JA; Salazar-Cifre A; Boscá-Blasco ME; del Olmo-Rodríguez A; Valero-Merino C; Muñoz-Lacalle RA;
    Rev Neurol; 2009 Oct 1-15; 49(7):337-42. PubMed ID: 19774526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Emergent psychopathology in Alzheimer's disease patients over 12 months associated with functional, not cognitive, changes.
    Tractenberg RE; Weiner MF; Patterson MB; Gamst A; Thal LJ
    J Geriatr Psychiatry Neurol; 2002; 15(2):110-7. PubMed ID: 12083593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Personality changes in Alzheimer's disease.
    Bózzola FG; Gorelick PB; Freels S
    Arch Neurol; 1992 Mar; 49(3):297-300. PubMed ID: 1536633
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical utility of the functional independence measure for assessment of patients with Alzheimer's disease and vascular dementia.
    Tanaka N; Nakatsuka M; Ishii H; Nakayama R; Hosaka R; Meguro K
    Psychogeriatrics; 2013 Dec; 13(4):199-205. PubMed ID: 24289460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The need for a consensus in the use of assessment tools for Alzheimer's disease: the Feasibility Study (assessment tools for dementia in Alzheimer Centres across Europe), a European Alzheimer's Disease Consortium's (EADC) survey.
    Paulino Ramirez Diaz S; Gil Gregório P; Manuel Ribera Casado J; Reynish E; Jean Ousset P; Vellas B; Salmon E
    Int J Geriatr Psychiatry; 2005 Aug; 20(8):744-8. PubMed ID: 16035121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired insight in Alzheimer disease: association with cognitive deficits, psychiatric symptoms, and behavioral disturbances.
    Harwood DG; Sultzer DL; Wheatley MV
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Apr; 13(2):83-8. PubMed ID: 10780626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.